BD0805848
N-Methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-aminehydrochloride , 97% , 1260590-51-9
Pack Size | Price | Stock | Quantity |
100mg | RMB100.80 | In Stock |
|
250mg | RMB150.40 | In Stock |
|
1g | RMB381.60 | In Stock |
|
5g | RMB1169.60 | In Stock |
|
others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
Melting point: | >225°C (dec.) |
storage temp. | under inert gas (nitrogen or Argon) at 2-8°C |
solubility | Aqueous Acid (Slightly, Sonicated), Aqueous Base (Slightly), Water (Slightly) |
form | Solid |
color | White to Off-White |
InChI | InChI=1/C13H19N5.ClH/c1-9-3-5-14-7-11(9)18(2)13-10-4-6-15-12(10)16-8-17-13;/h4,6,8-9,11,14H,3,5,7H2,1-2H3,(H,15,16,17);1H/t9-,11+;/s3 |
InChIKey | CJRKOJYCZNKFRI-YXFCPEPJNA-N |
SMILES | N([C@H]1CNCC[C@H]1C)(C1N=CN=C2NC=CC=12)C.Cl |&1:1,6,r| |
Description and Uses
N-Methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-7H-Pyrrolo[2,3-d]pyrimidin-4-amine Hydrochloride, is a substance used in the identification of related substances in the degradation products of tofacitinib citrate using LC-MS technique for process monitoring and quality assurance. A reagent for the synthesis of Tofacitinib (CP-690,550), a Janus tyrosine kinase (JAK3) specific inhibitor.